The Hidden Fat: Why Visceral Adipose Tissue Matters More Than the Number on the Scale
You eat well. You exercise. Your BMI is normal. So why should you worry about fat?
Because not all fat is created equal, and the fat you can't see may be the fat that matters most.
What Is Visceral Fat, and Why Should You Care?
When most people think about body fat, they picture the soft layer just beneath the skin, the kind you can pinch. That's subcutaneous fat, and while nobody loves it, it's relatively benign from a metabolic standpoint.
Visceral adipose tissue is different. It's the fat packed deep inside the abdomen, surrounding the liver, intestines, and other organs. Unlike subcutaneous fat, visceral fat is metabolically hyperactive. It pumps out inflammatory molecules, disrupts hormone signaling, and floods the liver with free fatty acids through the portal circulation, the direct highway between the gut and the liver.
The consequences are serious. Decades of research using advanced imaging have consistently shown that excess visceral fat, independent of total body fat or BMI, is linked to insulin resistance and type 2 diabetes, heart disease and atherosclerosis, high blood pressure, atherogenic dyslipidemia including high triglycerides, low HDL cholesterol, and small dense LDL particles, fatty liver disease, and chronic low-grade inflammation.
A Mendelian randomization study, a type of genetic analysis that can establish causation rather than just correlation, found that visceral fat is a causal risk factor for hypertension, heart attack, angina, type 2 diabetes, and high cholesterol. This isn't just an association. The fat itself is driving disease.
Perhaps most striking: at any given BMI, there can be a 2 to 3-fold variation in the amount of visceral fat between individuals. Two people who weigh the same and look similar on the outside can have dramatically different amounts of this dangerous internal fat, and dramatically different health trajectories as a result.
The Problem With BMI and Body Fat Percentage
BMI has been the standard metric for assessing weight-related health risk for decades. But it has a fundamental limitation: it tells you nothing about where your fat is stored or what kind of fat you're carrying.
Body fat percentage is a step up because it distinguishes fat from lean mass. But even this number can be misleading. A person with 18% body fat could have most of it stored harmlessly under the skin, or a disproportionate amount packed around their organs. The health implications of these two scenarios are vastly different.
This is where the concept of normal-weight obesity or metabolically unhealthy normal weight becomes important. Research has shown that lean individuals with excess visceral fat and low gluteofemoral fat in the hips and thighs can actually carry higher cardiometabolic risk than people classified as having metabolically healthy obesity. In other words, being thin doesn't guarantee metabolic health, and the scale can provide false reassurance.
Enter the DXA Scan: Seeing What the Scale Can't
Dual-energy X-ray absorptiometry, better known as a DXA scan, was originally developed to measure bone density. But modern DXA technology can do much more. It provides a detailed breakdown of body composition: bone mineral content, lean mass, and fat mass, region by region. Critically, newer DXA software can estimate visceral adipose tissue specifically.
How accurate is it? In a large study using the UK Biobank cohort of over 4,500 participants, DXA-derived visceral fat measurements showed an excellent correlation with MRI, the gold standard for measuring visceral fat. By comparison, bioelectrical impedance analysis, the technology used in most consumer smart scales, had a much weaker correlation. DXA isn't perfect and may slightly underestimate visceral fat in very lean individuals, but it's the most practical and accessible clinical tool available for quantifying this critical fat depot.
What makes DXA particularly valuable is its ability to differentiate. Two patients might both have 22% body fat on a DXA scan, but one might have 80 cm² of visceral fat while the other has 200 cm². That difference matters enormously for health risk, and it's invisible without this kind of imaging.
For those who want an even simpler screening tool, waist circumference remains surprisingly useful. It correlates well with imaging-based visceral fat measurements and is recommended by multiple medical societies as a complement to BMI in clinical evaluations. A tape measure won't give you the precision of a DXA scan, but it can raise a red flag.
Why Would a Fit, Lean Person Have High Visceral Fat?
This is the question that surprises people most. If someone exercises regularly, eats well, and maintains a healthy weight, how can they still accumulate excess visceral fat?
Several factors can contribute.
Genetics. This is probably the most common explanation. Just as some people are genetically predisposed to store fat in their hips and thighs, others are programmed to deposit fat viscerally. Ethnicity plays a role too. Individuals of South Asian and East Asian descent, for example, tend to accumulate more visceral fat at lower BMI levels compared to those of European or African descent.
Stress and cortisol. Chronic psychological stress activates the hypothalamic-pituitary-adrenal axis, leading to sustained cortisol elevation. Cortisol preferentially drives fat storage into the visceral compartment. This is relevant for high-performing professionals and athletes alike. Overtraining, sleep deprivation, and chronic life stress can all contribute. Visceral fat has more glucocorticoid receptors than subcutaneous fat, making it especially responsive to stress hormones.
Dietary quality, not just quantity. Calorie balance matters, but so does what those calories are made of. Diets high in refined carbohydrates, added sugars, and fructose, particularly from sugar-sweetened beverages, have been specifically linked to visceral fat accumulation, even when total caloric intake is appropriate. Alcohol, even in moderate amounts, can also preferentially increase visceral fat.
Hormonal changes. Declining testosterone in men and shifting estrogen levels in women, particularly around menopause but sometimes earlier, redirect fat storage toward the visceral compartment. This can begin subtly in the 30s and 40s, well before any obvious clinical signs.
Age. Independent of other factors, aging is associated with a selective increase in visceral fat deposition. This is one reason why metabolic risk can creep up even in people who maintain stable weight over the years.
Subcutaneous fat dysfunction. One emerging theory suggests that visceral fat accumulation is actually a consequence of subcutaneous fat reaching its storage capacity. When subcutaneous adipose tissue can't expand properly through healthy cell division, excess energy gets redirected to visceral and ectopic depots like the liver, pancreas, heart, and skeletal muscle. This overflow hypothesis helps explain why some lean individuals develop visceral obesity: their subcutaneous fat simply isn't equipped to handle the load.
What Can You Do About It?
The good news is that visceral fat is highly responsive to intervention, often more so than subcutaneous fat. A 5% reduction in body weight, for example, has been shown to produce a disproportionately larger decrease in visceral fat compared to total body fat.
Here's what the evidence supports.
Aerobic exercise is the most effective single intervention. A meta-analysis of randomized controlled trials found that aerobic exercise reduces visceral fat even in the absence of weight loss, by approximately 6.1% on average. High-intensity interval training and moderate-intensity sustained aerobic exercise like brisk walking for 30 to 60 minutes are both effective. Interestingly, resistance training alone has not consistently shown significant visceral fat reduction, though it has many other health benefits. The effective dose appears to be about three sessions per week for at least 12 weeks.
For someone who is already very active, the type and structure of exercise may matter more than the volume. If current training is heavily resistance-based or sport-specific, adding dedicated aerobic sessions, particularly HIIT, may help target visceral fat specifically.
Diet quality matters as much as quantity. Mediterranean-style dietary patterns, rich in vegetables, fruits, nuts, legumes, olive oil, and fish, have been consistently associated with lower visceral fat and reduced cardiovascular risk. The landmark PREDIMED trial showed a roughly 30% reduction in cardiovascular events with a Mediterranean diet, even without significant weight loss. Minimizing sugar-sweetened beverages and refined carbohydrates is particularly important, as these have been specifically correlated with visceral fat gain.
Stress management is underappreciated. Given the direct link between cortisol and visceral fat deposition, addressing chronic stress through sleep optimization, mindfulness practices, appropriate training periodization for athletes, and psychological support can have meaningful effects on visceral fat, even when diet and exercise are already optimized.
Hormonal evaluation may be warranted. For individuals with unexplained visceral fat accumulation, checking testosterone in men, relevant sex hormones, thyroid function, and screening for subtle cortisol excess can identify treatable contributors.
The Bottom Line
The number on the scale, and even your body fat percentage, tells an incomplete story. Visceral fat is a distinct, metabolically dangerous fat depot that independently drives cardiovascular disease, diabetes, and metabolic dysfunction. It can accumulate even in lean, active individuals due to genetics, stress, dietary composition, hormonal shifts, and aging.
DXA scanning offers a practical, accessible way to quantify visceral fat and distinguish it from the relatively benign subcutaneous variety. For anyone serious about understanding their true metabolic health, not just their weight, knowing their visceral fat status is one of the most valuable data points available.
The encouraging news: visceral fat responds to targeted intervention. Aerobic exercise, dietary quality improvements, stress management, and when indicated, hormonal optimization can meaningfully reduce this hidden risk factor, even in people who are already fit and active.
Sometimes the most important health metric is the one you can't see in the mirror.
References
Stefan N. Causes, Consequences, and Treatment of Metabolically Unhealthy Fat Distribution. The Lancet Diabetes and Endocrinology. 2020.
Després JP, Carpentier AC, Tchernof A, Neeland IJ, Poirier P. Management of Obesity in Cardiovascular Practice: JACC Focus Seminar. Journal of the American College of Cardiology. 2021.
Neeland IJ, Ross R, Després JP, et al. Visceral and Ectopic Fat, Atherosclerosis, and Cardiometabolic Disease: A Position Statement. The Lancet Diabetes and Endocrinology. 2019.
Chan B, Yu Y, Huang F, Vardhanabhuti V. Towards Visceral Fat Estimation at Population Scale. Frontiers in Endocrinology. 2023.
Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021.
Chang YH, Yang HY, Shun SC. Effect of Exercise Intervention Dosage on Reducing Visceral Adipose Tissue: A Systematic Review and Network Meta-Analysis. International Journal of Obesity. 2021.
Cornier MA, Després JP, Davis N, et al. Assessing Adiposity: A Scientific Statement From the American Heart Association. Circulation. 2011.
Wang D, Morton JI, Salim A, Magliano DJ, Shaw JE. Comparison of DXA, BIA, and Anthropometry for Assessing Subcutaneous, Visceral, Liver, and Pancreas Fat Measured by MRI. Diabetes, Obesity and Metabolism. 2026.
Maskarinec G, Shvetsov YB, Wong MC, et al. Subcutaneous and Visceral Fat Assessment by DXA and MRI in Older Adults and Children. Obesity. 2022.
Tchernof A, Després JP. Pathophysiology of Human Visceral Obesity: An Update. Physiological Reviews. 2013.
Taylor JL, Holland DJ, Coombes JS, Keating SE. Accuracy of DXA for Assessing Longitudinal Change in Visceral Adipose Tissue in Patients With Coronary Artery Disease. International Journal of Obesity. 2021.
Dr. Schraga is a concierge physician at Crescendo MD in Portola Valley, California, specializing in preventive and longevity medicine for executives and families in Silicon Valley.
